not tagged
Not Tagged
[]
dynamic trial: compared to control, ctdna-guided adjuv therapy in stage ii colon cancer pts showed: non-inferior 2y-rfs less adjuv chemo (15% vs 28%). outstanding work. should ctdna be routinely used in stage ii pts? some thoughts #asco22 
??Medical Oncologist, MSc, PhD. GI/neuroendocrine/GU tumors/breast cancer ??Hospital Universitario UFC-CE, Oncologia D’Or